MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$1,535K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Prepaid expenses and other curre...
Accounts payable
Negative Cash Flow Breakdown
Stock-based compensation
Accrued expenses and other curre...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-1,581
-1,621
686
-7,564
Depreciation and amortization
-
-
54
128
Non-cash operating lease cost
-
-
0
96
Impairment of right-of-use assets
-
-
0
1,411
Gain on extinguishment of debt
-
-
5,793
-
(gain) loss on fair value remeasurement of contingent consideration
-
-
0
4,833
Amortization of debt discount and other non-cash interest
-
-
-1,142
116
Stock-based compensation
-136
-471
401
2,044
Issuance of common stock for service contract
0
1,755
1,553
-
Issuance of common stock for settlement agreements
-
-
524
-
Loss on sale or disposal of property and equipment
-
-
-549
-
Prepaid expenses and other current assets
-201
1,621
-1,245
1,457
Other long-term assets
-
-
-151
-
Accounts payable
98
58
69
259
Accrued expenses and other current liabilities
-117
-995
-1,313
-984
Lease liabilities and other long-term liabilities
-
-
-1,533
-100
Net cash used in operating activities
-1,535
-2,895
-4,556
-10,877
Payment for short-term investment
0
7,000
0
-1
Net cash used in investing activities
0
-7,000
0
1
Payment of principal and payment fee on debt
-
-
19,913
0
Payment of issuance costs from issuance of common stock and series i preferred stock
-
-
0
0
Proceeds from issuance of series aaa preferred stock, net of issuance cost
0
4,102
1,800
-
Proceeds from common stock offerings, net of offering costs of 866
-
-
9,134
-
Payment of principal on finance lease
-
-
4
30
Proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan
-
-
0
60
Net cash provided by (used in) financing activities
0
4,102
-8,983
30
Net (decrease) increase in cash and cash equivalents
-1,535
-5,793
-13,539
-10,846
Cash and cash equivalents at beginning of period
1,764
7,557
21,096
51,181
Cash and cash equivalents at end of period
229
1,764
7,557
21,096
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net (decrease)
increase in cash and cash...
-$1,535K
(92.02%↑ Y/Y)
Prepaid expenses and
other current assets
-$201K
(-291.43%↓ Y/Y)
Accounts payable
$98K
(226.67%↑ Y/Y)
Net cash used in
operating activities
-$1,535K
(90.73%↑ Y/Y)
Canceled cashflow
$299K
Net loss
-$1,581K
(92.14%↑ Y/Y)
Stock-based compensation
-$136K
(-102.99%↓ Y/Y)
Accrued expenses and
other current...
-$117K
(92.67%↑ Y/Y)
Buy us a coffee
KALA BIO, Inc. (KALA)
KALA BIO, Inc. (KALA)